Pluri Inc. Partners' Capital Account, Units, Sold in Public Offering
Pluri Inc. (PLUR) reported Partners' Capital Account, Units, Sold in Public Offering of 8.00 million shares for the 1-month period ending 2012-09-30, per its 10-K filed 2013-09-11.
Discontinued
us-gaap:PartnersCapitalAccountUnitsSoldInPublicOffering · last filed 2013-09-11
- 2012-09-30: Partners' Capital Account, Units, Sold in Public Offering 1 month 8.00M shares.
- 2012-09-19: Partners' Capital Account, Units, Sold in Public Offering 0 month 8.00M shares.
- 2011-02-01: Partners' Capital Account, Units, Sold in Public Offering 0 month 11.00M shares; Partners' Capital Account, Units, Sold in Public Offering 1 month 11.00M shares.
| Period end | Partners' Capital Account, Units, Sold in Public Offering 0 month | Partners' Capital Account, Units, Sold in Public Offering 1 month |
|---|---|---|
| 2012-09-30 | 8.00M shares 10-K · filed 2013-09-11 | |
| 2012-09-19 | 8.00M shares 10-Q · filed 2013-01-31 | |
| 2011-02-01 | 11.00M shares 10-K · filed 2012-09-10 | 11.00M shares 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |